DAVIS SELECTED ADVISERS - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.

Quarter-by-quarter ownership
DAVIS SELECTED ADVISERS ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2017$43,213,000
-57.5%
3,917,812
-44.0%
0.19%
-58.2%
Q4 2016$101,644,000
-43.8%
7,000,303
-5.0%
0.44%
-43.5%
Q3 2016$180,816,000
+22.9%
7,365,210
+0.8%
0.79%
+21.6%
Q2 2016$147,118,000
-22.7%
7,304,762
+0.9%
0.65%
-23.0%
Q1 2016$190,421,000
-50.5%
7,240,337
+91.3%
0.84%
-47.5%
Q4 2015$384,645,000
+42.9%
3,784,012
+150.7%
1.60%
+43.8%
Q3 2015$269,197,000
-31.2%
1,509,122
-14.4%
1.12%
-18.5%
Q2 2015$391,481,000
+5.0%
1,762,238
-6.1%
1.37%
+7.9%
Q1 2015$372,817,000
-25.7%
1,877,040
-46.5%
1.27%
-21.8%
Q4 2014$502,053,000
+8.4%
3,508,163
-0.6%
1.62%
+12.9%
Q3 2014$463,013,000
+16.4%
3,529,237
+11.9%
1.44%
+21.6%
Q2 2014$397,815,000
+11.0%
3,153,748
+16.0%
1.18%
+19.9%
Q1 2014$358,335,000
+3029.6%
2,718,162
+2686.9%
0.99%
+3425.0%
Q4 2013$11,450,000
-5.0%
97,534
-15.6%
0.03%
-9.7%
Q3 2013$12,055,000
+5.6%
115,544
-12.8%
0.03%
+6.9%
Q2 2013$11,412,000132,5790.03%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2014
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,586,582$864,160,00032.02%
FARLEY CAPITAL L.P. 341,518$44,807,00030.12%
LeVasseur Capital Partners LLC 190,404$24,981,00029.94%
Ruane, Cunniff & Goldfarb 34,494,015$4,525,615,00023.97%
ValueAct Holdings 18,923,877$2,482,813,00016.64%
White River Investment Partners, LLC 90,099$11,820,00016.35%
Tesuji Partners 1,368,040$179,487,00015.45%
Arrow Capital Management, LLC 197,500$25,912,00015.11%
Hound Partners 3,576,998$469,302,00014.87%
Brahman Capital Corp. 4,457,153$584,778,00012.82%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders